alcon ag - ALC

ALC

Close Chg Chg %
80.74 -1.18 -1.46%

Closed Market

79.56

-1.18 (1.46%)

Volume: 985.92K

Last Updated:

Apr 16, 2026, 3:59 PM EDT

Company Overview: alcon ag - ALC

ALC Key Data

Open

$81.20

Day Range

79.53 - 81.30

52 Week Range

71.55 - 99.20

Market Cap

$39.35B

Shares Outstanding

487.40M

Public Float

481.80M

Beta

1.03

Rev. Per Employee

N/A

P/E Ratio

40.63

EPS

$1.99

Yield

39.53%

Dividend

$0.36

EX-DIVIDEND DATE

May 6, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.43M

 

ALC Performance

1 Week
 
1.97%
 
1 Month
 
8.01%
 
3 Months
 
0.70%
 
1 Year
 
-14.04%
 
5 Years
 
7.24%
 

ALC Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 24
Full Ratings ➔

About alcon ag - ALC

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.

ALC At a Glance

Alcon AG
Royce Bedward
Geneva, Geneve (Geneva) 1214
Phone 41-817-293-04-50 Revenue 10.40B
Industry Medical Specialties Net Income 980.00M
Sector Health Technology 2025 Sales Growth 4.944%
Fiscal Year-end 12 / 2026 Employees 25,942
View SEC Filings

ALC Valuation

P/E Current 40.629
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 40.264
Price to Sales Ratio 3.817
Price to Book Ratio 1.77
Price to Cash Flow Ratio 17.48
Enterprise Value to EBITDA 16.057
Enterprise Value to Sales 4.167
Total Debt to Enterprise Value 0.121

ALC Efficiency

Revenue/Employee 400,932.85
Income Per Employee 37,776.579
Receivables Turnover 4.793
Total Asset Turnover 0.336

ALC Liquidity

Current Ratio 2.115
Quick Ratio 1.331
Cash Ratio 0.527

ALC Profitability

Gross Margin 55.235
Operating Margin 13.114
Pretax Margin 11.326
Net Margin 9.422
Return on Assets 3.166
Return on Equity 4.497
Return on Total Capital 3.592
Return on Invested Capital 3.688

ALC Capital Structure

Total Debt to Total Equity 23.809
Total Debt to Total Capital 19.23
Total Debt to Total Assets 16.625
Long-Term Debt to Equity 20.836
Long-Term Debt to Total Capital 16.829
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Alcon Ag - ALC

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
8.72B 9.46B 9.91B 10.40B
Sales Growth
+5.14% +8.47% +4.82% +4.94%
Cost of Goods Sold (COGS) incl D&A
3.91B 4.20B 4.40B 4.66B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.12B 1.22B 1.23B 1.33B
Depreciation
408.00M 476.00M 476.00M 506.00M
Amortization of Intangibles
715.00M 745.00M 752.00M 829.00M
COGS Growth
+8.52% +7.44% +4.64% +5.91%
Gross Income
4.81B 5.25B 5.51B 5.75B
Gross Income Growth
+2.54% +9.30% +4.97% +4.17%
Gross Profit Margin
+55.15% +55.57% +55.65% +55.24%
2022 2023 2024 2025 5-year trend
SG&A Expense
3.65B 4.04B 4.13B 4.38B
Research & Development
702.00M 828.00M 876.00M 990.00M
Other SG&A
2.95B 3.21B 3.25B 3.39B
SGA Growth
-1.59% +10.57% +2.20% +6.18%
Other Operating Expense
- - 176.00M 36.00M
-
Unusual Expense
308.00M 142.00M 4.00M (63.00M)
EBIT after Unusual Expense
672.00M 1.04B 1.39B 1.43B
Non Operating Income/Expense
(75.00M) (18.00M) 71.00M (45.00M)
Non-Operating Interest Income
16.00M 45.00M 84.00M 74.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
134.00M 189.00M 192.00M 204.00M
Interest Expense Growth
+11.67% +41.04% +1.59% +6.25%
Gross Interest Expense
134.00M 189.00M 192.00M 204.00M
Interest Capitalized
- - - -
-
Pretax Income
463.00M 832.00M 1.26B 1.18B
Pretax Income Growth
+10.77% +79.70% +51.92% -6.80%
Pretax Margin
+5.31% +8.80% +12.75% +11.33%
Income Tax
128.00M (142.00M) 238.00M 180.00M
Income Tax - Current - Domestic
17.00M 74.00M 95.00M 80.00M
Income Tax - Current - Foreign
146.00M 93.00M 239.00M 106.00M
Income Tax - Deferred - Domestic
(53.00M) (313.00M) (25.00M) (25.00M)
Income Tax - Deferred - Foreign
18.00M 4.00M (71.00M) 19.00M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
335.00M 974.00M 1.02B 980.00M
Minority Interest Expense
- - - -
-
Net Income
335.00M 974.00M 1.02B 980.00M
Net Income Growth
-10.90% +190.75% +4.52% -3.73%
Net Margin Growth
+3.84% +10.30% +10.27% +9.42%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
335.00M 974.00M 1.02B 980.00M
Preferred Dividends
- - - -
-
Net Income Available to Common
335.00M 974.00M 1.02B 980.00M
EPS (Basic)
0.6817 1.9757 2.0591 1.987
EPS (Basic) Growth
-11.17% +189.82% +4.22% -3.50%
Basic Shares Outstanding
491.40M 493.00M 494.40M 493.20M
EPS (Diluted)
0.6776 1.9617 2.0462 1.975
EPS (Diluted) Growth
-11.09% +189.51% +4.31% -3.48%
Diluted Shares Outstanding
494.40M 496.50M 497.50M 496.20M
EBITDA
2.10B 2.40B 2.62B 2.70B
EBITDA Growth
-1.17% +14.22% +8.95% +3.13%
EBITDA Margin
+24.13% +25.40% +26.41% +25.95%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 96.373
Number of Ratings 24 Current Quarters Estimate 0.796
FY Report Date 06 / 2026 Current Year's Estimate 3.439
Last Quarter’s Earnings 0.81 Median PE on CY Estimate N/A
Year Ago Earnings 3.07 Next Fiscal Year Estimate 3.929
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 16 25 25
Mean Estimate 0.80 0.88 3.44 3.93
High Estimates 0.85 0.94 3.49 4.11
Low Estimate 0.74 0.85 3.39 3.72
Coefficient of Variance 3.75 2.42 0.73 2.62

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 14 13 12
OVERWEIGHT 4 5 5
HOLD 6 5 8
UNDERWEIGHT 0 0 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Alcon Ag in the News